Sammy Basso, Progeria Advocate and Researcher, Dies at 28
Key Insights
Sammy Basso, a prominent advocate and researcher for progeria (search), passed away at the age of 28 due to suspected cardiovascular complications.
Basso volunteered for clinical trials of the first approved drug for progeria (search), which slows the disease's progression and extends patients' lives.
He was an active member of a research team working on gene-editing therapy for progeria (search), contributing significantly to the scientific efforts.
Sammy Basso, a biologist and leading voice in the progeria (search) patient community, has died at the age of 28. Basso's sudden death, suspected to be from cardiovascular complications associated with progeria, marks a significant loss for the rare disease community. He was known for his advocacy, scientific contributions, and ability to find humor even in the face of a challenging condition.
Life with Progeria
Diagnosed with progeria (search), also known as Hutchinson-Gilford syndrome (search), at age 2, Basso lived with a genetic condition that accelerates aging. This rare disease, caused by a single genetic mutation leading to a toxic protein buildup, typically results in severe cardiovascular problems and a shortened lifespan, often with patients dying around the age of 14. Despite these challenges, Basso lived a life marked by resilience and determination.
Contributions to Progeria Research
Basso was actively involved in advancing progeria (search) research. He volunteered for clinical trials that led to the first approved drug for the disease, which helps prevent the accumulation of the toxic protein and slows the progression of symptoms. Furthermore, he was a key member of a research team focused on developing a gene-editing therapy aimed at correcting the genetic defect responsible for progeria.
Francis Collins, former director of the National Institutes of Health (NIH), noted Basso's integral role in the research team: "He helped us every time we met to keep our eyes on what we were trying to do, which was not just an academic exercise."
Advocacy and Impact
Beyond his scientific contributions, Basso was a powerful advocate for the progeria (search) community. He used his experiences to connect with others, raise awareness, and inspire hope. Leslie Gordon, medical director of the Progeria Research Foundation (search), emphasized Basso's multifaceted role, from being a childhood friend of her son to becoming a valued research collaborator.
Basso's impact extended beyond the scientific and medical fields. He earned a master's degree in molecular biology and was considering pursuing a Ph.D. His ability to balance his scientific pursuits with a deep sense of empathy and humor made him a unique and influential figure. As David Liu, of Harvard and the Broad Institute, stated, "Sammy had a magical way of unifying others and moving us to be better versions of ourselves."
Sammy Basso's legacy will endure through his contributions to progeria (search) research, his advocacy for the rare disease community, and the inspiration he provided to those who knew him.